BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smythe MA, Burns C, Liu Q, Garwood CL. Potential Dexamethasone-Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID? Ann Pharmacother 2021;:10600280211025042. [PMID: 34137279 DOI: 10.1177/10600280211025042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Potere N, Candeloro M, Porreca E, Marinari S, Federici C, Auciello R, Di Nisio M. Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone. J Thromb Thrombolysis 2021. [PMID: 34498156 DOI: 10.1007/s11239-021-02561-w] [Reference Citation Analysis]
2 Lasica R, Djukanovic L, Mrdovic I, Savic L, Ristic A, Zdravkovic M, Simic D, Krljanac G, Popovic D, Simeunovic D, Rajic D, Asanin M. Acute Coronary Syndrome in the COVID-19 Era-Differences and Dilemmas Compared to the Pre-COVID-19 Era. J Clin Med 2022;11:3024. [PMID: 35683411 DOI: 10.3390/jcm11113024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ferri N, Colombo E, Tenconi M, Baldessin L, Corsini A. Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice. Pharmaceutics 2022;14:1120. [DOI: 10.3390/pharmaceutics14061120] [Reference Citation Analysis]